Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-be nzyl)oxy]-phenethyl}amino)methyl] benzoic acid

Details for Australian Patent Application No. 2007271431 (hide)

Owner Bayer Healthcare AG

Inventors Kuhn, Bernd; Wagner, Daniel

Agent Davies Collison Cave

Pub. Number AU-A-2007271431

PCT Pub. Number WO2008/003414

Priority 10 2006 031 175.2 06.07.06 DE

Filing date 26 June 2007

Wipo publication date 10 January 2008

International Classifications

A61K 31/197 (2006.01)

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/003414 Priority application(s): WO2008/003414

14 May 2009 Assignment before Grant

  Bayer Healthcare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271449-Pharmaceutical composition containing a tetrahydrofolic acid

2007271404-Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects